Research Article
The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer
Table 1
Clinical characteristics of the liver cancer patients.
| Characteristics | Numbers of cases (%) |
| Age | | <55 | 117 (31.45) | ≥55 | 255 (68.55) | Gender | | Female | 121 (32.44) | Male | 252 (67.56) | Histological type | | Fibrolamellar carcinoma | 3 (0.8) | Hepatocellular carcinoma | 363 (97.32) | Hepatocholangiocarcinoma (mixed) | 7 (1.88) | Histologic grade | | NA | 5 (1.34) | G1 | 55 (14.75) | G2 | 178 (47.72) | G3 | 123 (32.98) | G4 | 12 (3.22) | Stage | | NA | 24 (6.43) | I | 172 (46.11) | II | 87 (23.32) | III | 85 (22.79) | IV | 5 (1.34) | T classification | | NA | 2 (0.54) | T1 | 182 (48.79) | T2 | 95 (25.47) | T3 | 80 (21.45) | T4 | 13 (3.49) | TX | 1 (0.27) | N classification | | NA | 1 (0.27) | N0 | 253 (67.83) | N1 | 4 (1.07) | NX | 115 (30.83) | M classification | | M0 | 267 (71.58) | M1 | 4 (1.07) | MX | 102 (27.35) | Radiation therapy | | NA | 25 (6.7) | No | 340 (91.15) | Yes | 8 (2.14) | Residual tumor | | NA | 7 (1.88) | R0 | 326 (87.4) | R1 | 17 (4.56) | R2 | 1 (0.27) | RX | 22 (5.9) | Vital status | | Deceased | 130 (34.85) | Living | 243 (65.15) | Sample type | | Primary tumor | 371 (99.46) | Recurrent tumor | 2 (0.54) | Os_s | | 0 | 237 (64.58) | 1 | 130 (35.42) | Rf_s | | 0 | 179 (55.94) | 1 | 141 (44.06) | INPP5K | | High | 225 (60.32) | Low | 148 (39.68) | Type | | 1 | 373 (100) |
|
|